MTOR and lung adenocarcinoma: For the first time, we demonstrate that ViceninII targets the TGF-β/Smad and PI3K/Akt/mTOR pathways to inhibit TGF-β1-induced EMT phenotypes in lung adenocarcinoma A549 and H1299 cells.